HarbourVest Global Private Equity (HVPE)
The HarbourVest team has been investing in the private markets for over 30 years, gaining invaluable expertise and developing long-term relationships with sought-after partners. Our approach is characterized by consistency and continuity while also adapting to meet client needs. Over the years, we have continually identified opportunities to provide early access to the evolving private equity landscape – secondary investing (since 1986), Europe market (since 1984), Asia market (since 1984) – and expanded our local teams around the globe.
Horizon Discovery (HZD)
Horizon Discovery is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. Horizon’s proprietary gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23,000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer. These models have been adopted by c1,400 unique organisations to better understand of the genetic drivers of disease, and by Horizon in a range of services offered to customers as well as in the Company’s own R&D pipeline.